13F Holdings
中文EN

ICCM IceCure Medical Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1584371 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY2.7%
TTM net income YoY1.7%
TTM EPS YoY-20.0%
Revenue 3-yr CAGR3.1%
Net income 3-yr CAGR—

Margins

Gross margin36.3%
Operating margin-446.7%
Net margin-445.6%
FCF margin-432.4%
EBITDA margin-438.0%

Returns

ROE-188.8%
ROA-113.8%
ROIC (approx.)—
Asset turnover0.26x

Leverage & solvency

Liabilities / assets34.8%
Debt / equity0.00x
Current ratio2.61x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.38M$3.29M$3.23M$3.08M$4.14M
Cost of revenue$2.15M$1.84M$1.93M$1.64M$1.94M
Gross profit$1.23M$1.45M$1.30M$1.45M$2.19M
R&D expense$7.43M$7.10M$8.27M$9.12M$5.88M
SG&A expense$4.53M$3.75M$4.17M$5.86M$4.12M
Operating income-$15.09M-$15.70M-$15.58M-$16.74M-$9.72M
Net income-$15.06M-$15.32M-$14.65M-$16.98M-$9.89M
EBITDA-$14.80M-$15.36M-$15.25M-$16.49M-$9.60M
EPS (basic)0.240.300.320.460.35
EPS (diluted)0.240.300.320.460.35
Weighted avg. shares (diluted)63.58M50.88M45.64M37.02M28.55M
Banking
Deposits——$20,000$20,000$20,000
Balance sheet
Cash & equivalents$8.90M$7.56M$10.53M$23.66M$25.62M
Short-term investments——$529,000——
Receivables$331,000$221,000$103,000$78,000$456,000
Inventory$2.62M$1.99M$2.27M$2.86M$1.96M
Current assets$12.61M$10.75M$14.18M$28.13M$30.32M
PP&E, net$993,000$1.25M$1.51M$1.36M$713,000
Total assets$13.89M$12.58M$16.41M$30.19M$32.28M
Current liabilities$4.82M$5.51M$3.87M$4.34M$4.02M
Long-term debt$13,000$161,000———
Total debt$13,000$161,000———
Total liabilities$4.84M$5.67M$4.25M$4.77M$5.32M
Shareholders' equity$9.05M$6.90M$12.16M$25.42M$26.96M
Net debt-$8.88M-$7.40M———
Shares outstanding73.12M56.57M45.73M45.62M35.78M
Cash flow statement
Operating cash flow-$14.57M-$12.56M-$12.55M-$14.29M-$12.61M
Capital expenditure$36,000$71,000$480,000$891,000$533,000
Free cash flow-$14.61M-$12.63M-$13.03M-$15.18M-$13.14M
Investing cash flow-$36,000$446,000-$684,000-$891,000$3.79M
Financing cash flow$15.83M$9.19M$83,000$13.58M$30.89M
Depreciation & amortization$295,000$332,000$323,000$248,000$127,000
Stock-based compensation$1.37M$869,000$1.31M$1.86M$316,000

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.